Longwood Fund, L.p. - Net Worth and Insider Trading

Longwood Fund, L.p. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Longwood Fund, L.p. owns 3 companies in total, including Millendo Therapeutics Inc (MLND) , Verastem Inc (VSTM) , and Tempest Therapeutics Inc (TPST) .

Click here to see the complete history of Longwood Fund, L.p.’s form 4 insider trades.

Insider Ownership Summary of Longwood Fund, L.p.

Ticker	Comapny	Transaction Date	Type of Owner
MLND	Millendo Therapeutics Inc	2015-01-14	10 percent owner
VSTM	Verastem Inc	2014-01-24	10 percent owner
TPST	Tempest Therapeutics Inc	2014-03-07	10 percent owner

Longwood Fund, L.p. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Longwood Fund, L.p. Ownership Network

Ownership Network List of Longwood Fund, L.p.

No Data

Ownership Network Relation of Longwood Fund, L.p.

Longwood Fund, L.p. Owned Company Details

What does Millendo Therapeutics Inc do?

Who are the key executives at Millendo Therapeutics Inc?

Longwood Fund, L.p. is the 10 percent owner of Millendo Therapeutics Inc. Other key executives at Millendo Therapeutics Inc include Chief Medical Officer Christophe Arbet-engels , Chief Development Officer Ryan Zeidan , and director & President and CEO Julia C. Owens .

Millendo Therapeutics Inc (MLND) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Millendo Therapeutics Inc (MLND) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Millendo Therapeutics Inc (MLND) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Millendo Therapeutics Inc (MLND)'s detailed insider trading history can be found in Insider Trading Tracker table.

Millendo Therapeutics Inc Insider Transactions

No Available Data

What does Verastem Inc do?

Who are the key executives at Verastem Inc?

Longwood Fund, L.p. is the 10 percent owner of Verastem Inc. Other key executives at Verastem Inc include Chief Financial Officer Robert E. Gagnon , Chief Operating Officer Dan Paterson , and Vice President of Finance Daniel Calkins .

Verastem Inc (VSTM) Insider Trades Summary

Over the past 18 months, Longwood Fund, L.p. made no insider transaction in Verastem Inc (VSTM). Other recent insider transactions involving Verastem Inc (VSTM) include a net sale of 1,022 shares made by Daniel Calkins , a net sale of 20,757 shares made by Robert E. Gagnon , and a net sale of 5,621 shares made by Dan Paterson .

In summary, during the past 3 months, insiders sold 4,413 shares of Verastem Inc (VSTM) in total and bought 0 shares, with a net sale of 4,413 shares. During the past 18 months, 31,598 shares of Verastem Inc (VSTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 31,598 shares.

Verastem Inc (VSTM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Verastem Inc Insider Transactions

No Available Data

What does Tempest Therapeutics Inc do?

Who are the key executives at Tempest Therapeutics Inc?

Longwood Fund, L.p. is the 10 percent owner of Tempest Therapeutics Inc. Other key executives at Tempest Therapeutics Inc include 10 percent owner Versant Venture Capital Vi, L.p. , director & Chief Executive Officer Stephen R Brady , and Chief Medical Officer Samuel Whiting .

Tempest Therapeutics Inc (TPST) Insider Trades Summary

Over the past 18 months, Longwood Fund, L.p. made no insider transaction in Tempest Therapeutics Inc (TPST). Other recent insider transactions involving Tempest Therapeutics Inc (TPST) include a net sale of 787,999 shares made by Versant Venture Capital Vi, L.p. , a net purchase of 35,000 shares made by Stephen R Brady , and a net purchase of 4,672 shares made by Samuel Whiting .

In summary, during the past 3 months, insiders sold 787,999 shares of Tempest Therapeutics Inc (TPST) in total and bought 39,672 shares, with a net sale of 748,327 shares. During the past 18 months, 787,999 shares of Tempest Therapeutics Inc (TPST) were sold and 39,672 shares were bought by its insiders, resulting in a net sale of 748,327 shares.

Tempest Therapeutics Inc (TPST)'s detailed insider trading history can be found in Insider Trading Tracker table.

Tempest Therapeutics Inc Insider Transactions

No Available Data

Longwood Fund, L.p. Mailing Address

Above is the net worth, insider trading, and ownership report for Longwood Fund, L.p.. You might contact Longwood Fund, L.p. via mailing address: 800 Boylston Suite 1555, Boston Ma 02199.

Discussions on Longwood Fund, L.p.

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.